NCT05317819Phase 3Recruiting

Study of ADI-PEG 20 Versus Placebo in Subjects With High Arginine Level and Unresectable Hepatocellular Carcinoma

Study sponsor: Polaris Group

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2028-09Estimated
Enrollment · participants300Estimated
Source updated2025-12-18Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters

· 1 field changed

Primary completion date changed

Before: Sep 2025. After: Sep 2028.

Check registry source

Explore older trial changes

Upgrade to Pro to see the full available history for this trial.

Upgrade to Pro Illustrative preview